Langasog, Fe L.

HRN: 18-87-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/07/2026
07/13/2026
IV
4.5 G IV LD Then 2.25 G IV
Q6
CAP WITH HAP COMPONENT
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines